Bronchiolitis obliterans with organizing
✍
Suzanne E. Biehn; David Kirk; M. Patricia Rivera; Antonio E. Martinez; Amir H. K
📂
Article
📅
2006
🏛
John Wiley and Sons
🌐
English
⚖ 151 KB
## Abstract Rituximab is a chimeric, anti‐CD20 monoclonal antibody initially approved for relapsed, refractory indolent B‐cell non‐Hodgkin's lymphoma (NHL), and is being applied in an increasing variety of clinical scenarios. Most adverse events are due to an infusion‐related symptom complex, and s